DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 017364
The generic ingredient in AQUATENSEN is methyclothiazide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyclothiazide profile page.
Summary for 017364
Tradename: | AQUATENSEN |
Applicant: | Medpointe Pharm Hlc |
Ingredient: | methyclothiazide |
Patents: | 0 |
Therapeutic Class: | Cardiovascular Agents |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 017364
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription